+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmaceutical Gelatin Market by Source, Type, Function, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5201060
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pharmaceutical Gelatin Market grew from USD 1.20 billion in 2023 to USD 1.28 billion in 2024. It is expected to continue growing at a CAGR of 6.44%, reaching USD 1.86 billion by 2030.

Pharmaceutical gelatin is a crucial component in drug formulation, acting primarily as a binding agent, film-coating agent, and in the encapsulation of medications. It is a versatile excipient derived from animal collagen, commonly used for its biodegradability and excellent biocompatibility. The necessity of pharmaceutical gelatin lies in its gels' thermo-reversible nature and ability to protect sensitive substances, enhancing the stability and bioavailability of drugs. Its application spans hard and soft gelatin capsules, tableting, and as a plasma expander, with its end-use primarily in pharmaceutical and nutraceutical industries. Market growth is driven by the rising demand for capsule-based drugs, growing consumer preference for preventive health measures, and technological advancements facilitating innovative drug delivery systems. Emerging markets in Asia-Pacific and increasing R&D in orally disintegrating and controlled-release formulations highlight potential opportunities. Companies can capitalize on these growth areas by investing in process innovations and expanding product portfolios to include gelatin-based offerings addressing specific therapeutic areas. However, the market faces challenges such as stringent regulatory frameworks, ethical concerns regarding animal-derived products, and competition from plant-based gelatin alternatives. These factors can limit market expansion and demand adaptability from manufacturers. To foster innovation, companies should explore hybrid gelatin technologies blending traditional materials with plant-based or synthetic compounds to enhance functionality and cater to vegan or vegetarian preferences. Continuous research into bioengineering processes to improve the efficiency and sustainability of gelatin production is also critical. The market's competitive nature demands strategic alignments, including mergers, acquisitions, and partnerships with biotech firms, to leverage advanced technologies and enhance production capabilities. In summary, the market for pharmaceutical gelatin presents several growth opportunities facilitated by technological integration and strategic expansions, but it demands agile adaptation to regulatory, ethical, and consumer preference shifts.

Understanding Market Dynamics in the Pharmaceutical Gelatin Market

The Pharmaceutical Gelatin Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Large scale use of gelatin in pharma drug dosage
    • Prevalence of chronic and infectious disorders
    • Increasing clinical trials and preliminary drug studies
  • Market Restraints
    • High cost associated with Pharmaceutical Gelatin
  • Market Opportunities
    • Recent advancements in gelatin nanoparticle in vaccine and drug delivery
    • Improvements in supply chain and distribution network
  • Market Challenges
    • Safety and quality concerns with pharmaceutical gelatin

Exploring Porter’s Five Forces for the Pharmaceutical Gelatin Market

Porter’s Five Forces framework further strengthens the insights of the Pharmaceutical Gelatin Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Pharmaceutical Gelatin Market

External macro-environmental factors deeply influence the performance of the Pharmaceutical Gelatin Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Pharmaceutical Gelatin Market

The Pharmaceutical Gelatin Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Pharmaceutical Gelatin Market

The Pharmaceutical Gelatin Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Pharmaceutical Gelatin Market

The Pharmaceutical Gelatin Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Gelatin Market, highlighting leading vendors and their innovative profiles. These include Gelco International, Gelita AG, Gelnex, Geltec Private Limited, Geltech Co. Ltd., Henan Boom Gelatin Co. Ltd., India Gelatine & Chemicals Ltd., Italgel S.r.l., Juncà Gelatines SL, Kenney & Ross Limited, Lapi Gelatine S.p.A, SAS Gelatines Weishardt, Tessenderlo Group NV, Toudongbao Biotechnology Co., Ltd., and Xiamen Gelken Gelatin Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Gelatin Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Source
    • Bovine Bone
    • Bovine Skin
    • Marine
    • Porcine
    • Poultry
  • Type
    • Type A
    • Type B
  • Function
    • Gelling Agents
    • Stabilizing Agents
    • Thickening Agents
  • Application
    • Absorbable Hemostats
    • Hard Capsules
    • Soft Capsules
    • Tablets
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Large scale use of gelatin in pharma drug dosage
5.1.1.2. Prevalence of chronic and infectious disorders
5.1.1.3. Increasing clinical trials and preliminary drug studies
5.1.2. Restraints
5.1.2.1. High cost associated with Pharmaceutical Gelatin
5.1.3. Opportunities
5.1.3.1. Recent advancements in gelatin nanoparticle in vaccine and drug delivery
5.1.3.2. Improvements in supply chain and distribution network
5.1.4. Challenges
5.1.4.1. Safety and quality concerns with pharmaceutical gelatin
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Pharmaceutical Gelatin Market, by Source
6.1. Introduction
6.2. Bovine Bone
6.3. Bovine Skin
6.4. Marine
6.5. Porcine
6.6. Poultry
7. Pharmaceutical Gelatin Market, by Type
7.1. Introduction
7.2. Type A
7.3. Type B
8. Pharmaceutical Gelatin Market, by Function
8.1. Introduction
8.2. Gelling Agents
8.3. Stabilizing Agents
8.4. Thickening Agents
9. Pharmaceutical Gelatin Market, by Application
9.1. Introduction
9.2. Absorbable Hemostats
9.3. Hard Capsules
9.4. Soft Capsules
9.5. Tablets
10. Americas Pharmaceutical Gelatin Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pharmaceutical Gelatin Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Pharmaceutical Gelatin Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. PHARMACEUTICAL GELATIN MARKET RESEARCH PROCESS
FIGURE 2. PHARMACEUTICAL GELATIN MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PHARMACEUTICAL GELATIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PHARMACEUTICAL GELATIN MARKET DYNAMICS
TABLE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE BONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE SKIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY MARINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY GELLING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY STABILIZING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY THICKENING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ABSORBABLE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 39. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 41. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 45. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 61. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 63. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 65. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 67. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 75. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 99. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 112. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 116. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 120. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 124. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 128. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 134. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 136. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 148. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 150. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 152. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 154. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 156. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 172. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 184. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 194. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Pharmaceutical Gelatin Market, which are profiled in this report, include:
  • Gelco International
  • Gelita AG
  • Gelnex
  • Geltec Private Limited
  • Geltech Co. Ltd.
  • Henan Boom Gelatin Co. Ltd.
  • India Gelatine & Chemicals Ltd.
  • Italgel S.r.l.
  • Juncà Gelatines SL
  • Kenney & Ross Limited
  • Lapi Gelatine S.p.A
  • SAS Gelatines Weishardt
  • Tessenderlo Group NV
  • Toudongbao Biotechnology Co., Ltd.
  • Xiamen Gelken Gelatin Co., Ltd.

Methodology

Loading
LOADING...

Table Information